Post ASCO 2021 What Changes Monday Morning? Live Q&A Panels
S

Post ASCO 2021 Expert Panel Discussion on GI Cancers: Topic Selection on CRC and Upper GI Hepatobiliary & Pancreatic Cancers

By Post ASCO 2021 What Changes Monday Morning? Live Q&A Panels FEATURING Shikha Jain, Michael Gibson, Samuel Klempner, Louise Connell
By Post ASCO 2021 What Changes Monday Morning? Live Q&A Panels FEATURING Shikha Jain, Michael Gibson, Samuel Klempner, Louise Connell
185 views
July 9, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Related Videos

Miami Cancer Institute Precision Oncology Symposium

Miami Cancer Institute Precision Oncology Symposium 2025

Fri, Feb 7, 2025
Total Health

Cancer Updates GI and Breast

Thu, Feb 6, 2025
See 3 others
18:21

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

882 views
14:19

ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose

2024 ESMO Annual Meeting Insights Hub

H. Hochster

552 views
20:09

ESMO 2024 Summary: Selecting 1L Therapy and Sequencing After Immunot…

2024 ESMO Annual Meeting Insights Hub

L. Rimassa

435 views
32:47

Multidisciplinary Approach to Hepatocellular Carcinoma

UCLA Health

G. Choi, B. Yanny, S. Sadeghi, J. Hui

272 views
17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

2.1K views
21:33

New

Year in Review 2024 - Hepatobiliary Cancers

Oncology 2024 Year in Review

R. Kim, T. Biachi

222 views
14:02

ESMO 2024 Summary: Highlights in CRC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

252 views
04:43

1L Botensilimab + Balstilimab in Stage IV MSS CRC Without Liver Mets…

Nicholas DeVito

163 views
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views
04:39

ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - P…

2024 ESMO Annual Meeting Insights Hub

J. Llovet

211 views
14:28

ESMO 2024 Summary: Updates in HCC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

H. Babiker

184 views
16:57

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

683 views
05:40

ESMO 2024 Insights: CheckMate 9DW Expanded Analysis - Nivo + Ipi vs.…

2024 ESMO Annual Meeting Insights Hub

H. Karachiwala

143 views
03:26

Expert Panel on TACE and TARE for HCC: Weighing the Pros and Cons

Integrity CE

M. Pishvaian, R. Salem

102 views
09:56

ESMO 2024 Insights: HIMALAYA - 5-Year OS of Tremelimumab + Durvaluma…

2024 ESMO Annual Meeting Insights Hub

L. Rimassa

177 views
27:04

Cancer Screening Molecular Tools

Fengting Yan

2.5K views
15:31

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

314 views
55:10

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

331 views
20:26

Choosing the Best HCC Treatment Based on Patient and Disease Stage

Integrity CE

M. Pishvaian, R. Finn, R. Salem, A. Singal

137 views
22:27

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

546 views
AUTOPLAY